– Reuters
Monness, Crespi, Hardt Upgrades Skechers USA to Buy, Announces $55 Price Target
Monness, Crespi, Hardt analyst Jim Chartier upgrades Skechers USA (NYSE:SKX) from Neutral to Buy and announces $55 price target.
Earlier, NY Fed Said ‘The Global Supply Chains Have Returned To Normal’
– Reuters
Related Posts
EPA Lists TOMI Environmental Solutions On List Q: Disinfectants For Emerging Viral Pathogens (EVPs)
https://www.epa.gov/pesticide-registration/disinfectants-emerging-viral-pathogens-evps-list-q
AnPac Bio-Medical Science Q1 Sales $309.00K Down From $333.00K YoY
AnPac Bio-Medical Science (NASDAQ:ANPC) reported $309.00 thousand in sales this quarter. This is a 7.21 percent decrease over sales of $333.00 thousand the same period last year.
‘Crypto traders are pinning at least part of the digital-coin surge on doubts that @SECGov chief @GaryGensler has the authority for the massive crackdown he recently called for…’ -Tweet From FOX’s Charlie Gasparino
https://twitter.com/CGasparino/status/1427670254977695749